~~<i id='D2BD84DCB2'><strike id='D2BD84DCB2'><tt id='D2BD84DCB2'><pre id='D2BD84DCB2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：entertainment 2025-09-27 07:51:15 - browse：82

LONDON — AstraZeneca said Thursday it would purchase the French firm Amolyt Pharma in a deal worth up to $1 billion, picking up a rare disease drug in a pivotal trial.

The acquisition includes an upfront payment of $800 million in cash, plus another $250 million if regulatory milestones are met.

AstraZeneca framed the deal for Amolyt, which has focused on treatments for rare endocrine diseases, as a boost for its own rare disease pipeline.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Let's speed up science by embracing open access publishing

hotspot

Wikipedia

entertainment

hotspot

APStockSixyearsago,HarvardscientistJayBradnerdiscoveredsomethingunusual.Hislaboratoryhadisolatedamol

WSS

FDA's Pazdur wants cancer trials to range beyond China alone

US judge blocks portions of new Florida elections law

Russians and Belarusians back at Wimbledon as war in Ukraine continues

ASCO: Palliative care found as helpful given virtually as in person

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

At ASCO, AstraZeneca reports strong data for breast cancer drug

focus

focus

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare can notify patients about the breach, HHS says

Affirmative action in medical school literally saved lives

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Malaria cases in Florida and Texas: Here’s what you need to know

Cord blood banking comes at a high cost to babies

Malaria cases in Florida and Texas: Here’s what you need to know

10 states plan to sue EPA over standards for residential wood

Wikipedia

The Pandemic Treaty must support building strong health systems

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

entertainment

entertainment

hotspot

hotspot